Creating cures from stem cell research

Neuralstem, Inc. is a publicly traded biotherapeutics company whose mission is to apply stem cell research and its patented human neural stem cell technology to treat diseases of the central nervous system including Ischemic Paraplegia, Traumatic Spinal Cord Injury, ALS and Parkinson’s Disease.

A Neuroscience Breakthrough

Our stem cell research has resulted in a patent-protected technology that allows us to produce mature, commercial quantities of neural stem cells with the ability to control the differentiation of the cells into physiologically relevant human neurons and glia. Once approved by the FDA, these cells could be transplanted into humans as treatments for currently incurable diseases.

Investigational New Drugs

New information coming soon.  Please check back.

Neuralstem is a proud Sponsor of the National Veterans Wheelchair Games.

Microsoft Money contributing writer Michael Brush recommends Neuralstem for model portfolio. Please read the full article: 5 hot stocks at Big Mac prices.

View our safe harbour statement.